Pheochromocytoma nursing: pathophysiology, diagnosis, and NCLEX review

Pheochromocytoma is a catecholamine-secreting tumor of the adrenal medulla that produces paroxysmal or sustained hypertension, dramatic cardiovascular instability, and, if mismanaged, life-threatening crises. It is rare — affecting roughly 0.2 to 0.6% of hypertensive patients — but its clinical consequences are disproportionate to its prevalence. Missed diagnosis carries a mortality risk from hypertensive stroke, myocardial infarction, or arrhythmia.

For nursing students, pheochromocytoma is high-yield for two reasons. First, NCLEX consistently tests the alpha-before-beta blockade rule: giving a beta blocker before establishing alpha blockade can trigger a paradoxical, potentially fatal hypertensive crisis. Second, the perioperative management involves a specific, counterintuitive protocol — including a high-salt diet before surgery — that nurses must understand and teach. This reference covers the complete clinical picture: pathophysiology, the 10% rule, diagnostic workup, medication sequencing, preoperative priorities, intraoperative and postoperative nursing care, patient education, and 12 NCLEX-high-yield tips. Read it alongside the hypertension nursing reference for blood pressure management context, the Addison’s disease nursing reference for adrenal insufficiency management after bilateral adrenalectomy, and the Cushing’s syndrome nursing reference for the broader adrenal disease cluster.

Pathophysiology

Chromaffin cells and catecholamine synthesis

The adrenal medulla is embryologically derived from neural crest cells and is functionally an extension of the sympathetic nervous system. Its chromaffin cells synthesize and store catecholamines — primarily epinephrine (about 80%) and norepinephrine (about 20%) — and release them in response to sympathetic stimulation. A pheochromocytoma is a tumor of these chromaffin cells that secretes catecholamines autonomously, independent of normal physiological feedback.

When catecholamines are released in excess, they activate both alpha-adrenergic and beta-adrenergic receptors throughout the body. Alpha-1 receptor activation causes vasoconstriction of peripheral arterioles, dramatically increasing systemic vascular resistance and blood pressure. Alpha-2 receptors modulate norepinephrine release and cause some vasodilation. Beta-1 receptor activation increases heart rate, contractility, and conduction velocity. Beta-2 receptor activation causes vasodilation in skeletal muscle beds, bronchodilation, and glycogenolysis. The net cardiovascular effect of a catecholamine surge is hypertension — often severe and sudden — combined with tachycardia, increased cardiac output, and the risk of arrhythmia.

Epinephrine-dominant tumors tend to produce more profound tachycardia, diaphoresis, and hypoglycemia rebound (from beta-2-mediated glycogenolysis followed by insulin surge). Norepinephrine-dominant tumors produce more intense vasoconstriction and hypertension with relatively less tachycardia — sometimes presenting with reflex bradycardia because the baroreflex fires in response to extreme blood pressure elevation.

The 10% rule

Traditionally taught as the “10% rule,” pheochromocytoma has several characteristics that occur in roughly 10% of cases:

• 10% are malignant — no reliable histological marker distinguishes benign from malignant; malignancy is defined by metastasis to sites where chromaffin tissue is not normally present (bone, liver, lung, lymph nodes).
• 10% are bilateral — both adrenal glands are affected; more common in familial syndromes.
• 10% are extraadrenal (paragangliomas) — arise from sympathetic ganglia outside the adrenal medulla; the organ of Zuckerkandl near the aortic bifurcation is the most common extraadrenal site.
• 10% occur in children — pheos are more likely to be extraadrenal and bilateral in pediatric patients.
• 10% are familial — inherited in association with multiple endocrine neoplasia type 2A (MEN2A: pheochromocytoma + medullary thyroid carcinoma + primary hyperparathyroidism), MEN2B (pheochromocytoma + medullary thyroid carcinoma + mucosal neuromas), von Hippel-Lindau disease, or neurofibromatosis type 1. All patients with pheochromocytoma should be offered genetic testing.

Contemporary series suggest the actual proportion of familial and malignant cases is higher than 10%, but the rule remains a useful NCLEX framework.

Clinical presentation

The classic triad

The hallmark of pheochromocytoma is the paroxysm: an episodic attack of headache, diaphoresis, and palpitations that correlates with catecholamine release from the tumor. Paroxysms may last minutes to hours and can occur multiple times daily or as infrequently as monthly. Between attacks, patients may feel completely normal — a pattern that frequently delays diagnosis.

During a paroxysm:

• Headache is typically pulsatile and severe, reflecting the acute blood pressure elevation.
• Diaphoresis is generalized and can be drenching.
• Palpitations arise from tachycardia and increased cardiac contractility.
• Pallor (vasoconstriction-mediated) is more common than flushing — distinguishing pheo from carcinoid syndrome, which typically causes flushing.
• Systolic blood pressure often exceeds 200 mmHg and may reach 300 mmHg.
• Anxiety, sense of impending doom, tremor, and chest pain are common accompaniments.

Sustained versus paroxysmal hypertension

About half of patients have sustained hypertension that is resistant to standard antihypertensive therapy. The remainder have episodic hypertension with normal blood pressure between attacks, or occasionally normal blood pressure throughout (particularly with dopamine-secreting tumors). A small subset of patients — sometimes called “silent pheo” — present with minimal symptoms until an acute trigger provokes a crisis, typically during a procedure or surgery.

Triggers

A critical nursing priority is recognizing and avoiding triggers that can precipitate a hypertensive crisis:

• Abdominal palpation of the tumor — direct mechanical catecholamine release; nurses must not palpate the abdomen of a suspected or confirmed pheo patient
• Emotional or physical stress
• Exercise
• Anesthesia induction — intubation and volatile anesthetic agents can trigger massive release
• Certain medications:
  • Beta-blockers given without prior alpha blockade (see Medical management section)
  • Tricyclic antidepressants (block catecholamine reuptake → potentiate effects)
  • Opioids (especially morphine — histamine release can trigger paroxysm)
  • Glucagon (direct stimulant of catecholamine release — used historically as a provocation test)
  • Metoclopramide (dopamine antagonist that can trigger release)
  • Tyramine-containing foods in some patients
• Contrast dye (ionic contrast media can trigger release — use non-ionic agents with premedication)
• Micturition (if tumor is in the bladder — rare but characteristic)

Catecholamine type and clinical pattern

Diagnostics

Biochemical testing

The cornerstone of pheochromocytoma diagnosis is demonstrating excess catecholamine production biochemically before imaging is ordered.

24-hour urine metanephrines and catecholamines — This is the most sensitive first-line test for patients with moderate clinical suspicion. Metanephrines (normetanephrine and metanephrine) are the methylated metabolites of norepinephrine and epinephrine, respectively. Because metanephrines are produced continuously by the tumor even between paroxysms, 24-hour urine collection captures this sustained excess more reliably than a spot measurement during a symptom-free interval. Sensitivity is approximately 86–97%.

Plasma free metanephrines — High sensitivity (96–100%), making this the preferred test when clinical suspicion is high (familial syndromes, prior pheo, incidentally found adrenal mass with classic symptoms). The trade-off is lower specificity — false-positive rates are higher, particularly with renal failure, anxiety, or certain medications (tricyclics, methyldopa, levodopa). Patients must avoid caffeine, strenuous exercise, and smoking for at least 12 hours before the test, and blood should ideally be drawn after 20–30 minutes of supine rest.

Clonidine suppression test — Used only when plasma metanephrines are borderline and clinical suspicion is moderate. Clonidine suppresses neurally-mediated catecholamine release in normal individuals; pheo-related secretion is autonomous and not suppressed. Pitfalls: test interpretation requires careful attention to timing and baseline values; false results occur with renal impairment or certain drugs. Not a first-line test.

Imaging

Imaging is ordered only after biochemistry confirms catecholamine excess — imaging alone is insufficient to diagnose pheo because incidental adrenal masses (“incidentalomas”) are common.

CT abdomen/pelvis — First-line imaging once biochemistry is positive. Sensitivity for adrenal pheo exceeds 90%. Pheos are typically vascular, heterogeneous masses, often >3 cm, with characteristic high attenuation on non-contrast CT (HU >10) and rich contrast enhancement. Non-ionic contrast is preferred to minimize the risk of triggering catecholamine release.

MRI — Preferred over CT in pregnant patients, children, patients with iodine contrast allergy, and when radiation exposure is a concern. Pheos show characteristic hyperintensity on T2-weighted sequences (“light bulb sign”).

MIBG scintigraphy (metaiodobenzylguanidine scan) — Functional imaging that identifies sites of catecholamine uptake across the entire body. Used when extraadrenal disease is suspected, CT/MRI fails to localize the tumor, or metastatic disease is being assessed. MIBG is taken up by chromaffin tissue; areas of uptake correlate with active tumor. Medications that interfere with MIBG uptake (tricyclics, calcium channel blockers, labetalol, decongestants) must be stopped before the scan.

Medical management: the alpha-before-beta blockade rule

This is the single most tested nursing concept in pheochromocytoma management, and the logic behind it must be understood — not simply memorized.

Why alpha blockade must come first

In the presence of a pheochromocytoma, circulating catecholamines continuously stimulate both alpha-adrenergic and beta-adrenergic receptors. The clinical result is hypertension (alpha-1-mediated vasoconstriction) combined with tachycardia (beta-1-mediated).

If a beta blocker is given first, it blocks beta-2 receptors in peripheral blood vessels. Beta-2 receptors are vasodilatory — they oppose alpha-1-mediated vasoconstriction in skeletal muscle vascular beds. Blocking them leaves alpha-1 stimulation completely unopposed. The result is paradoxical severe hypertension: blood pressure rises dramatically because the vasodilatory counterbalance has been removed while the vasoconstrictive drive remains intact. Additionally, the blocked beta-1 receptors prevent compensatory heart rate increase, so the heart cannot increase output to meet demand — contributing to cardiovascular collapse on top of hypertensive crisis. This scenario is potentially fatal.

The correct sequence is:

1. Alpha blockade first — start phenoxybenzamine (or an alternative alpha blocker) and maintain it for 10 to 14 days before surgery. This allows peripheral vasodilation, lowers blood pressure, and — critically — permits the vascular bed to re-expand, enabling volume repletion.
2. Beta blocker added only after alpha blockade is established — once adequate alpha blockade is in place, a beta blocker (typically propranolol or atenolol) is added to control the reflex tachycardia that phenoxybenzamine causes.

Phenoxybenzamine

Phenoxybenzamine (Dibenzyline) is the preferred agent for preoperative alpha blockade at most centers:

• Mechanism: Non-competitive (irreversible) alpha-1 and alpha-2 blocker — once bound, the drug cannot be displaced by catecholamines, making it effective even during intraoperative tumor manipulation surges.
• Dose: Typically started at 10 mg twice daily and titrated upward over days, targeting a blood pressure <130/80 mmHg preoperatively.
• Key side effects:
  • Orthostatic hypotension — expected and dose-related; fall precautions are mandatory
  • Reflex tachycardia — results from alpha-2 blockade (reduces presynaptic norepinephrine feedback) and from the drop in BP; this is why a beta blocker is added after
  • Nasal congestion — alpha-1 blockade in nasal mucosa causes vasodilation; patients should be warned
  • Inhibition of ejaculation in male patients

Alternative alpha blockers: Selective alpha-1 blockers (doxazosin, prazosin) are used at some centers and have fewer side effects, but their competitive mechanism means they can be overcome by the massive catecholamine surges during tumor manipulation — phenoxybenzamine’s irreversible binding is an advantage intraoperatively.

Phentolamine

Phentolamine is a short-acting, competitive alpha blocker used for acute hypertensive crisis management — during a paroxysm in the ward or for intraoperative hypertensive surges during tumor manipulation. It is given IV and its effects last 10–15 minutes, allowing rapid titration. Sodium nitroprusside is an alternative for intraoperative hypertension.

Calcium channel blockers

Calcium channel blockers (nicardipine, amlodipine) are sometimes added as adjuncts, particularly for patients who cannot tolerate phenoxybenzamine. They are not sufficient as sole agents for surgical preparation.

Pheochromocytoma versus other hypertensive conditions

Preoperative nursing priorities

The 10–14 days before surgery are the most critical nursing management period. The goals are blood pressure control, volume repletion, and avoidance of triggers.

Blood pressure and heart rate targets

• Target preoperative blood pressure: <130/80 mmHg sitting; systolic >90 mmHg standing (some orthostatic drop is expected and acceptable with phenoxybenzamine).
• After beta blocker is added: target resting heart rate 60–70 bpm.
• Monitor BP frequently — at minimum every shift, including orthostatic measurements (lying, sitting, standing). Document orthostatic drops and fall risk.

High-sodium, high-fluid diet

This is counterintuitive and a frequent NCLEX distractor. Phenoxybenzamine causes vasodilation across the peripheral vascular bed. As that bed expands, the existing circulating volume is relatively insufficient — patients develop phenoxybenzamine-induced volume contraction even though their fluid intake is unchanged. If this is not corrected before surgery, the sudden drop in catecholamines after tumor removal (which removes the vasoconstriction holding volume distribution in check) produces profound postoperative hypotension.

The solution is deliberate volume loading before surgery: a high-sodium diet (encouraged sodium intake of 5,000–8,000 mg/day) combined with liberal oral fluid intake. This expands intravascular volume in advance, buffering the postoperative catecholamine crash. Nurses must educate patients on this explicitly — it contradicts the standard advice for hypertensive patients, which typically restricts sodium.

Trigger avoidance

• No abdominal palpation — nursing staff, students, and consulting providers must be alerted. Post a sign at the bedside if the patient is hospitalized.
• No beta-blockers unless alpha blockade is already established.
• Avoid opioids if possible; if pain management requires them, use with caution and premedication.
• Non-ionic IV contrast only if imaging is needed.
• Limit emotional stressors; ensure a calm environment.

Fall precautions

Orthostatic hypotension from phenoxybenzamine is predictable and often significant. Implement fall precautions: bed in lowest position, call bell within reach, supervised first ambulation with each nursing shift, non-slip footwear, and patient education about rising slowly.

Patient education

Educate patients on:

• Why they are eating more salt and drinking more fluids — the rationale (vasodilation from medication requires volume expansion preoperatively)
• The importance of not skipping phenoxybenzamine doses
• Recognizing and reporting paroxysm symptoms
• Orthostatic dizziness — rise slowly from lying to sitting, pause, then stand
• What to expect after surgery: a likely period of low blood pressure and possible low blood sugar, managed with IV fluids and glucose monitoring

Intraoperative and postoperative nursing care

Intraoperative

During laparoscopic or open adrenalectomy, manipulation of the tumor causes an acute catecholamine surge regardless of preoperative preparation — but preoperative alpha blockade significantly attenuates the response. The anesthesia team must have phentolamine and nitroprusside immediately available.

Intraoperative hypertensive crisis (SBP >200 mmHg or sudden severe BP elevation) is treated with phentolamine IV (1–5 mg bolus) or a nitroprusside infusion. The nurse circulator must anticipate these orders and confirm drugs are drawn up and labeled before skin incision.

Arrhythmia management (typically ventricular arrhythmias from catecholamine excess) requires IV lidocaine or magnesium; beta blockers may be given intraoperatively once alpha blockade is confirmed adequate.

Postoperative: the catecholamine drop

After the tumor is removed and ligated from its blood supply, circulating catecholamines fall rapidly. The two expected consequences are:

Hypotension — Profound vasodilation without catecholamine-driven vasoconstriction. The preoperative volume loading with high-sodium diet is intended to buffer this. Despite preparation, aggressive IV fluid resuscitation is almost always required. Vasopressors may be needed transiently; norepinephrine is the agent of choice if fluids alone are insufficient. Monitor BP continuously via arterial line in the immediate postoperative period.

Hypoglycemia — Catecholamines drive glycogenolysis and suppress insulin secretion. When catecholamines fall abruptly, insulin surges unchecked, and blood glucose drops. Check blood glucose every 1–2 hours in the immediate postoperative period. Have 50% dextrose (D50W) available at the bedside. Maintain IV dextrose-containing fluids.

Nursing monitoring priorities in the 24–48 hours postoperatively:

• Continuous BP monitoring (arterial line or frequent cuff at minimum every 15 minutes initially)
• Blood glucose every 1–2 hours
• Intake and output every hour — fluid balance is critical
• Signs of adrenal insufficiency if bilateral adrenalectomy was performed (see below)
• Residual tumor function: catecholamine levels and BP typically normalize within 1–2 weeks if resection was complete

Bilateral adrenalectomy and adrenal insufficiency

If both adrenal glands are removed (required for bilateral pheo, most often in familial syndromes), the patient loses all cortisol and aldosterone production. Adrenal crisis is a risk in the perioperative period. Hydrocortisone stress dosing is given intraoperatively and tapered to maintenance levels over days. The patient will require lifelong glucocorticoid replacement (hydrocortisone or prednisone) and mineralocorticoid replacement (fludrocortisone). Nurses must ensure the patient and family understand this dependency before discharge. For a full framework on managing adrenal insufficiency, see the Addison’s disease nursing reference. For comparison with other endocrine emergencies, review the thyroid storm nursing reference.

Persistent hypertension postoperatively

Blood pressure may remain elevated for weeks after surgery as the vascular bed readjusts to lower catecholamine levels and as the residual alpha-adrenergic receptor downregulation resolves. This does not necessarily indicate residual or recurrent tumor. Full biochemical remission is confirmed by measuring plasma or urine metanephrines 4–6 weeks postoperatively. Long-term annual surveillance is recommended in familial cases.

Patient education

Before discharge, ensure the patient understands:

Medication compliance: Phenoxybenzamine and the beta blocker must be taken as prescribed without skipping doses. Missing a dose can trigger uncontrolled blood pressure swings before surgery.

Dietary instructions: High salt and fluid intake during the preoperative period is not a lifestyle choice — it is a clinical necessity. Patients accustomed to hearing “cut your sodium” from every healthcare provider may distrust this instruction. Explain the mechanism: the medication opens blood vessels, creating more space for the blood to fill; the extra salt and fluid fills that space. After surgery, standard dietary recommendations resume.

Trigger recognition and avoidance: Teach patients to avoid abdominal pressure or self-palpation, heavy lifting that increases intraabdominal pressure, and any new medication without telling their physician first. Provide a written list of drugs to avoid (beta-blockers without alpha coverage, TCAs, opioids, glucagon, metoclopramide). This is particularly relevant if the patient requires emergency surgery or anesthesia for an unrelated problem at another facility — they must alert the surgical team of their diagnosis.

Monitoring blood pressure at home: Teach patients how to take orthostatic BP readings. Reinforce that lightheadedness on standing is a known medication side effect and not a reason to stop taking the drug — but they should report it to their provider for dose adjustment. Review fall prevention: electrolyte imbalances nursing reference is a useful parallel for understanding how hemodynamic instability manifests clinically.

Post-surgical expectations: After surgery, blood pressure typically normalizes, and most patients feel dramatically better. The surgery is curative for the majority of benign pheos. However, surveillance (annual urine metanephrines) is recommended indefinitely for familial cases and for a minimum of 10 years in all cases, because recurrence and late metastasis can occur.

Genetic counseling: Because 10–40% of pheos are associated with an inherited syndrome (MEN2A, MEN2B, VHL, NF1), patients should be referred for genetic counseling and testing. If a germline mutation is identified, first-degree relatives require screening.

Renal monitoring: Persistent or recurrent hypertension can affect renal function over time. See the AKI nursing reference for context on hypertensive renal injury. Compare perioperative hemodynamic instability to the shock management principles in the septic shock nursing reference.

NCLEX high-yield tips

1. Alpha blockade must precede beta blockade. Giving a beta blocker before establishing alpha blockade in a pheo patient causes paradoxical severe hypertension — beta-2 vasodilation is blocked while alpha-1 vasoconstriction remains unopposed. This is the highest-yield NCLEX concept in pheochromocytoma.

2. The classic triad is headache, diaphoresis, and palpitations. These three together in a patient with paroxysmal hypertension should immediately raise suspicion for pheo.

3. 24-hour urine metanephrines are the most sensitive first-line biochemical test. Plasma free metanephrines are used when clinical suspicion is high (higher sensitivity, lower specificity).

4. Do not palpate the abdomen of a suspected or confirmed pheo patient. Mechanical pressure on the tumor triggers catecholamine release and can precipitate hypertensive crisis.

5. Phenoxybenzamine causes orthostatic hypotension and reflex tachycardia. Fall precautions are mandatory. The tachycardia is why a beta blocker is added — but only after alpha blockade is established.

6. High-salt diet and liberal fluids are prescribed preoperatively. This counteracts phenoxybenzamine-induced volume contraction and prevents severe hypotension after the tumor is removed. It contradicts the usual low-sodium advice for hypertensive patients — a classic NCLEX trick.

7. After tumor removal, expect hypotension and hypoglycemia. Catecholamines drop rapidly; the vasoconstrictive support disappears; insulin surges. Monitor glucose every 1–2 hours and have D50W at bedside.

8. Phentolamine IV is the drug for acute hypertensive crisis during surgery (or during a ward paroxysm). It is a short-acting, competitive alpha blocker. Sodium nitroprusside is an alternative.

9. The 10% rule: roughly 10% of pheos are malignant, bilateral, extraadrenal, pediatric, or familial. All five characteristics appear on NCLEX.

10. MEN2A association: pheochromocytoma + medullary thyroid carcinoma + primary hyperparathyroidism. MEN2B substitutes mucosal neuromas for hyperparathyroidism.

11. If bilateral adrenalectomy is performed: the patient needs lifelong glucocorticoid and mineralocorticoid replacement — the same as Addison’s disease. Hydrocortisone stress dosing is required perioperatively.

12. MIBG scintigraphy is used for extraadrenal and metastatic disease. CT localizes the primary adrenal tumor; MIBG finds disease throughout the body. Medications that block MIBG uptake (TCAs, labetalol, calcium channel blockers) must be stopped before the scan.

NCLEX-style practice questions

Question 1

A patient with confirmed pheochromocytoma is scheduled for adrenalectomy in 12 days. The provider orders metoprolol 25 mg twice daily for blood pressure control. Which action should the nurse take first?

A) Administer the metoprolol as ordered and monitor BP
B) Hold the metoprolol and notify the provider — alpha blockade has not been established
C) Administer the metoprolol with a glass of water and document
D) Check a 12-lead ECG before administering

Correct answer: B

Rationale: Beta blockers must never be given to a pheo patient before adequate alpha blockade is established. Metoprolol would block beta-2 vasodilatory receptors, leaving alpha-1 vasoconstriction unopposed — paradoxical severe hypertension results. The nurse’s first action is to hold the medication and notify the provider. The provider likely intended alpha blockade first (phenoxybenzamine) and this represents a prescription error that requires clarification before administration.

Question 2

A nurse is educating a patient with pheochromocytoma who will begin phenoxybenzamine tomorrow in preparation for surgery in two weeks. Which teaching point is most important to include?

A) “Restrict your sodium intake to less than 2,000 mg daily while on this medication.”
B) “Take this medication only when your blood pressure exceeds 160/100 mmHg.”
C) “Increase your salt and fluid intake and rise slowly from lying or sitting positions.”
D) “You may stop the medication if you feel dizzy — dizziness means your BP is too low.”

Correct answer: C

Rationale: Phenoxybenzamine causes peripheral vasodilation and volume contraction. Patients need increased sodium and fluid intake to expand intravascular volume and buffer the postoperative catecholamine drop. Orthostatic hypotension is an expected side effect; patients must rise slowly to avoid falls. Option A is wrong — low-sodium advice contradicts the required preoperative regimen. Options B and D describe incorrect medication management that would undermine preoperative preparation.

Question 3

Immediately after surgical removal of a pheochromocytoma, which two assessments are the nurse’s highest priority?

A) Temperature and respiratory rate
B) Blood pressure and blood glucose
C) Urine output and serum sodium
D) Heart rate and serum potassium

Correct answer: B

Rationale: After tumor removal, catecholamines fall abruptly. This produces hypotension (loss of catecholamine-driven vasoconstriction) and hypoglycemia (catecholamine-driven glycogenolysis ceases; insulin surges). Blood pressure monitoring via arterial line and blood glucose checks every 1–2 hours are the priority immediate postoperative assessments. Urine output (option C) is also monitored but is secondary to these two immediate hemodynamic and metabolic risks.

Question 4

A patient with pheochromocytoma is admitted for preoperative preparation. Which dietary instruction should the nurse provide?

A) Restrict sodium to 1,500 mg/day and limit fluid intake
B) Follow a cardiac-prudent low-fat, low-sodium diet
C) Eat a high-sodium diet and drink liberal amounts of fluid
D) Avoid all stimulants including caffeine and limit fluid to 1.5 L/day

Correct answer: C

Rationale: Phenoxybenzamine-induced vasodilation causes relative volume contraction. Eating a high-sodium diet and drinking liberal fluids expands intravascular volume, which prevents profound hypotension when catecholamines drop after tumor removal. This is an intentional exception to the usual low-sodium advice for hypertensive patients — a high-yield NCLEX distinction.

Question 5

Which statement best explains why the nurse must not perform abdominal palpation on a patient with pheochromocytoma?

A) Palpation may dislodge a clot over the tumor and cause hemorrhage
B) Abdominal palpation mechanically stimulates catecholamine release from the tumor, potentially triggering a hypertensive crisis
C) Palpation increases intraabdominal pressure, which reduces venous return
D) The patient may have undiagnosed ascites that palpation could rupture

Correct answer: B

Rationale: Mechanical pressure on the tumor directly stimulates catecholamine secretion, which can produce a rapid, severe hypertensive crisis. This is a critical nursing safety point — all team members caring for a pheo patient must be aware of this restriction. A sign at the bedside communicating “no abdominal palpation” is appropriate.

Related resources

• Hypertension nursing reference — blood pressure physiology, antihypertensive drug classes, and hypertensive emergency management
• Addison’s disease nursing reference — managing adrenal insufficiency, including post-bilateral adrenalectomy cortisol and aldosterone replacement
• Cushing’s syndrome nursing reference — adrenal cortex excess (the counterpart to pheo, which involves the medulla)
• Thyroid storm nursing reference — comparison endocrine emergency with similar hemodynamic instability and sequencing-dependent treatment
• Electrolyte imbalances nursing reference — glucose and electrolyte monitoring in perioperative management
• AKI nursing reference — renal consequences of prolonged or severe hypertension and perioperative hemodynamic instability
• Septic shock nursing reference — hemodynamic monitoring and vasopressor management principles that parallel pheo postoperative care
• Diabetes mellitus nursing reference — understanding post-tumor hypoglycemia in context of glucose regulation